2649 studies found for:    "Bone Diseases"
Show Display Options
Rank Status Study
21 Recruiting Evaluation and Treatment of Skeletal Diseases
Condition: Bone Disease
Intervention:
22 Completed CVD Risk and Health in Postmenopausal Phytoestrogen Users
Conditions: Bone Diseases;   Cardiovascular Diseases;   Coronary Disease;   Depression;   Heart Diseases;   Myocardial Ischemia;   Osteoporosis;   Postmenopause
Interventions: Behavioral: dietary supplements;   Drug: genistein;   Behavioral: diet, soy proteins
23 Completed A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation
Conditions: Osteoporosis;   Osteoporosis, Postmenopausal;   Bone Diseases
Intervention: Drug: ONO-5920 / YM529
24 Completed Women's Health Initiative (WHI)
Conditions: Bone Diseases;   Breast Neoplasms;   Cardiovascular Diseases;   Colonic Neoplasms;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Osteoporosis;   Postmenopause
Interventions: Drug: hormone replacement therapy;   Drug: estrogens;   Drug: progestins;   Drug: estrogen replacement therapy;   Behavioral: diet, fat-restricted;   Drug: calcium;   Drug: vitamin D;   Behavioral: dietary supplements
25 Completed Postmenopausal Estrogen/Progestin Interventions (PEPI)
Conditions: Bone Diseases;   Cardiovascular Diseases;   Coronary Disease;   Diabetes Mellitus;   Heart Diseases;   Hypercholesterolemia;   Hypertension;   Myocardial Ischemia;   Osteoporosis;   Thrombosis;   Postmenopause
Interventions: Drug: estrogens, conjugated;   Drug: medroxyprogesterone;   Drug: progesterone;   Drug: estrogen replacement therapy
26 Completed Outcomes of Sleep Disorders in Older Men
Conditions: Cardiovascular Diseases;   Heart Diseases;   Sleep;   Sleep Apnea Syndromes;   Neurologic Manifestations;   Osteoporosis;   Bone Diseases
Intervention: Procedure: Polysomnography
27 Completed Collection of Tissue Specimens for Analysis and Establishment of Cell Cultures
Conditions: Bone Diseases;   Connective Tissue Diseases
Intervention:
28 Completed A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Condition: Multiple Myeloma Bone Disease
Interventions: Drug: BHQ880;   Drug: Zoledronic acid
29 Not yet recruiting Bone Disease in Chronic Pancreatitis: A Complex Phenomenon
Conditions: Chronic Pancreatitis;   Osteopenia;   Osteoporosis
Intervention:
30 Completed Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.
Conditions: Osteopenia;   Osteoporosis;   Bone Disease
Intervention: Biological: RN564
31 Completed Study of Bone Disease in Older HIV-infected Adults
Conditions: Osteopenia;   Osteoporosis;   HIV Infection;   Aging;   HIV Infections
Intervention:
32 Completed Bisphosphonate Therapy for Osteogenesis Imperfecta
Conditions: Osteogenesis Imperfecta;   Osteoporosis;   Paget Disease of Bone
Interventions: Drug: Alendronate;   Drug: Pamidronate
33 Completed Re-treatment of Patients With Paget's Disease Using Zoledronic Acid
Condition: Paget's Disease of the Bone
Intervention: Drug: Zoledronic Acid
34 Completed
Has Results
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
Conditions: Breast Cancer;   Prostate Cancer;   Bone Neoplasms
Interventions: Drug: AZD0530;   Drug: Zoledronic Acid
35 Completed Electromagnetic Treatment For Bone Loss After Forearm Fracture
Conditions: Bone Disease, Metabolic;   Osteopenia;   Osteoporosis, Post-Traumatic
Intervention: Device: Pulsing electromagnetic field (PEMF)
36 Completed Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
Condition: Bone Disease, Metabolic
Interventions: Drug: Disodium pamidronate;   Drug: Placebo
37 Completed Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
Condition: Bone Diseases, Endocrine
Intervention:
38 Completed African-American Bone Metabolism and Lactation Study
Conditions: Lactation;   Bone Diseases, Endocrine
Intervention:
39 Completed Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
Conditions: Cystic Fibrosis;   Osteoporosis;   Bone Diseases, Metabolic
Interventions: Drug: Alendronate;   Drug: Placebo
40 Recruiting Patient Activation After DXA Result Notification
Conditions: Osteoporosis;   Bone Diseases, Metabolic
Intervention: Behavioral: Bone Mineral Density Result Letter and Bone Health Brochure

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years